ANI Pharmaceuticals Statistics

Total Valuation

BST:BSFA has a market cap or net worth of EUR 1.53 billion. The enterprise value is 1.81 billion.

Market Cap	1.53B
Enterprise Value	1.81B

Important Dates

The next confirmed earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	22.75M
Shares Outstanding	n/a
Shares Change (YoY)	+9.89%
Shares Change (QoQ)	+3.23%
Owned by Insiders (%)	5.43%
Owned by Institutions (%)	98.41%
Float	21.07M

Valuation Ratios

The trailing PE ratio is 25.50 and the forward PE ratio is 9.04.

PE Ratio	25.50
Forward PE	9.04
PS Ratio	2.03
PB Ratio	3.31
P/TBV Ratio	n/a
P/FCF Ratio	10.45
P/OCF Ratio	9.67
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.89, with an EV/FCF ratio of 12.40.

EV / Earnings	30.27
EV / Sales	2.40
EV / EBITDA	11.89
EV / EBIT	25.43
EV / FCF	12.40

Financial Position

The company has a current ratio of 2.71, with a Debt / Equity ratio of 1.16.

Current Ratio	2.71
Quick Ratio	2.07
Debt / Equity	1.16
Debt / EBITDA	3.52
Debt / FCF	3.67
Interest Coverage	2.59

Financial Efficiency

Return on equity (ROE) is 16.16% and return on invested capital (ROIC) is 7.83%.

Return on Equity (ROE)	16.16%
Return on Assets (ROA)	3.82%
Return on Invested Capital (ROIC)	7.83%
Return on Capital Employed (ROCE)	7.17%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	775,632
Profits Per Employee	61,653
Employee Count	970
Asset Turnover	0.65
Inventory Turnover	2.44

Taxes

In the past 12 months, BST:BSFA has paid 14.87 million in taxes.

Income Tax	14.87M
Effective Tax Rate	18.22%

Stock Price Statistics

The stock price has increased by +10.74% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+10.74%
50-Day Moving Average	65.28
200-Day Moving Average	69.88
Relative Strength Index (RSI)	51.90
Average Volume (20 Days)	8

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	9.75

Income Statement

In the last 12 months, BST:BSFA had revenue of EUR 752.36 million and earned 59.80 million in profits. Earnings per share was 2.83.

Revenue	752.36M
Gross Profit	461.67M
Operating Income	70.97M
Pretax Income	81.59M
Net Income	59.80M
EBITDA	148.83M
EBIT	70.97M
Earnings Per Share (EPS)	2.83

Balance Sheet

The company has 251.01 million in cash and 535.11 million in debt, giving a net cash position of -284.10 million.

Cash & Cash Equivalents	251.01M
Total Debt	535.11M
Net Cash	-284.10M
Net Cash Per Share	n/a
Equity (Book Value)	460.53M
Book Value Per Share	21.98
Working Capital	404.56M

Cash Flow

In the last 12 months, operating cash flow was 157.76 million and capital expenditures -11.78 million, giving a free cash flow of 145.97 million.

Operating Cash Flow	157.76M
Capital Expenditures	-11.78M
Depreciation & Amortization	78.05M
Net Borrowing	-8.67M
Free Cash Flow	145.97M
FCF Per Share	n/a

Margins

Gross margin is 61.36%, with operating and profit margins of 9.43% and 8.87%.

Gross Margin	61.36%
Operating Margin	9.43%
Pretax Margin	10.84%
Profit Margin	8.87%
EBITDA Margin	19.78%
EBIT Margin	9.43%
FCF Margin	19.40%

Dividends & Yields

BST:BSFA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	1.48%
Buyback Yield	-9.89%
Shareholder Yield	-9.89%
Earnings Yield	3.92%
FCF Yield	9.57%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BST:BSFA has an Altman Z-Score of 2.17 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.17
Piotroski F-Score	6